452 related articles for article (PubMed ID: 33918106)
1. Peptide-Based Strategies for Targeted Tumor Treatment and Imaging.
Ayo A; Laakkonen P
Pharmaceutics; 2021 Apr; 13(4):. PubMed ID: 33918106
[TBL] [Abstract][Full Text] [Related]
2. Tumor homing peptides as molecular probes for cancer therapeutics, diagnostics and theranostics.
Gautam A; Kapoor P; Chaudhary K; Kumar R; ; Raghava GP
Curr Med Chem; 2014; 21(21):2367-91. PubMed ID: 24533809
[TBL] [Abstract][Full Text] [Related]
3. Tumor-targeting peptides from combinatorial libraries.
Liu R; Li X; Xiao W; Lam KS
Adv Drug Deliv Rev; 2017 Feb; 110-111():13-37. PubMed ID: 27210583
[TBL] [Abstract][Full Text] [Related]
4. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
5. Peptides homing to tumor vasculature: imaging and therapeutics for cancer.
Liu Z; Wu K
Recent Pat Anticancer Drug Discov; 2008 Nov; 3(3):202-8. PubMed ID: 18991788
[TBL] [Abstract][Full Text] [Related]
6. Targeted Modification of the Cationic Anticancer Peptide HPRP-A1 with iRGD To Improve Specificity, Penetration, and Tumor-Tissue Accumulation.
Hu C; Huang Y; Chen Y
Mol Pharm; 2019 Feb; 16(2):561-572. PubMed ID: 30592418
[TBL] [Abstract][Full Text] [Related]
7. Application of phage display to discovery of tumor-specific homing peptides: developing strategies for therapy and molecular imaging of cancer.
Seung-Min L; Gil-Suk Y; Eun-Sang Y; Tae-Gyun K; In-San K; Byung-Heon L
Methods Mol Biol; 2009; 512():355-63. PubMed ID: 19347288
[TBL] [Abstract][Full Text] [Related]
8. From combinatorial chemistry to cancer-targeting peptides.
Aina OH; Liu R; Sutcliffe JL; Marik J; Pan CX; Lam KS
Mol Pharm; 2007; 4(5):631-51. PubMed ID: 17880166
[TBL] [Abstract][Full Text] [Related]
9. Lung Cancer-Targeting Peptides with Multi-subtype Indication for Combinational Drug Delivery and Molecular Imaging.
Chi YH; Hsiao JK; Lin MH; Chang C; Lan CH; Wu HC
Theranostics; 2017; 7(6):1612-1632. PubMed ID: 28529640
[TBL] [Abstract][Full Text] [Related]
10. The Challenge of Developing New Therapies for Childhood Cancers.
Balis FM
Oncologist; 1997; 2(1):I-II. PubMed ID: 10388032
[TBL] [Abstract][Full Text] [Related]
11. Improved breast cancer cell-specific intracellular drug delivery and therapeutic efficacy by coupling decoration with cell penetrating peptide and SP90 peptide.
Fan LQ; Du GX; Li PF; Li MW; Sun Y; Zhao LM
Biomed Pharmacother; 2016 Dec; 84():1783-1791. PubMed ID: 27899251
[TBL] [Abstract][Full Text] [Related]
12. Seek & Destroy, use of targeting peptides for cancer detection and drug delivery.
Le Joncour V; Laakkonen P
Bioorg Med Chem; 2018 Jun; 26(10):2797-2806. PubMed ID: 28893601
[TBL] [Abstract][Full Text] [Related]
13. Engineered Peptides for Applications in Cancer-Targeted Drug Delivery and Tumor Detection.
Soudy R; Byeon N; Raghuwanshi Y; Ahmed S; Lavasanifar A; Kaur K
Mini Rev Med Chem; 2017; 17(18):1696-1712. PubMed ID: 26891935
[TBL] [Abstract][Full Text] [Related]
14. Ligand-targeted theranostic nanomedicines against cancer.
Yao VJ; D'Angelo S; Butler KS; Theron C; Smith TL; Marchiò S; Gelovani JG; Sidman RL; Dobroff AS; Brinker CJ; Bradbury ARM; Arap W; Pasqualini R
J Control Release; 2016 Oct; 240():267-286. PubMed ID: 26772878
[TBL] [Abstract][Full Text] [Related]
15. Dual-drug RGD conjugates provide enhanced cytotoxicity to melanoma and non-small lung cancer cells.
Gilad Y; Noy E; Senderowitz H; Albeck A; Firer MA; Gellerman G
Biopolymers; 2016 Mar; 106(2):160-171. PubMed ID: 26715008
[TBL] [Abstract][Full Text] [Related]
16. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
17. Recognition Sites for Cancer-targeting Drug Delivery Systems.
Guan S; Zhang Q; Bao J; Hu R; Czech T; Tang J
Curr Drug Metab; 2019; 20(10):815-834. PubMed ID: 31580248
[TBL] [Abstract][Full Text] [Related]
18. Peritoneal Carcinomatosis Targeting with Tumor Homing Peptides.
Simón-Gracia L; Hunt H; Teesalu T
Molecules; 2018 May; 23(5):. PubMed ID: 29772690
[TBL] [Abstract][Full Text] [Related]
19. Anticancer activity of targeted proapoptotic peptides and chemotherapy is highly improved by targeted cell surface calreticulin-inducer peptides.
Obeid M
Mol Cancer Ther; 2009 Sep; 8(9):2693-707. PubMed ID: 19755516
[TBL] [Abstract][Full Text] [Related]
20. Targeting strategies for superparamagnetic iron oxide nanoparticles in cancer therapy.
Zhi D; Yang T; Yang J; Fu S; Zhang S
Acta Biomater; 2020 Jan; 102():13-34. PubMed ID: 31759124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
